Regenerex Pharma (RGPX) Gross Profit (2014 - 2020)
Regenerex Pharma (RGPX) reported Gross Profit of -$183.0 for Q4 2020, down 112.39% year-over-year from $1477.0 in Q1 2020, and down 312.79% quarter-over-quarter from $86.0 in Q3 2020.
Regenerex Pharma (RGPX) Gross Profit (2014 - 2020) Analysis & Trends
Regenerex Pharma (RGPX) has 3 years of Gross Profit data on file, last reported at -$183.0 in Q4 2020.
- Gross Profit for Q4 2020 came in at -$183.0, down 112.39% year-over-year; the trailing twelve-month figure through Dec 2020 was -$609.0 (changed N/A YoY), and the FY2020 annual result was $896.0, changed N/A from the prior year.
- Gross Profit slipped to -$183.0 in Q4 2020 per RGPX's latest filing, from $86.0 in the prior quarter.
- Over five years, Gross Profit peaked at $1477.0 in Q4 2019 and troughed at -$581.0 in Q1 2020.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -183.00 |
| Dec 31, 2020 | -183.00 |
| Sep 30, 2020 | 86.00 |
| Sep 30, 2020 | 86.00 |
| Jun 30, 2020 | 69.00 |
| Jun 30, 2020 | 69.00 |
| Mar 31, 2020 | -581.00 |
| Mar 31, 2020 | -581.00 |
| Dec 31, 2019 | 1,477.00 |
| Dec 31, 2019 | 1,477.00 |
| Aug 31, 2014 | 7,330.00 |
| Aug 31, 2014 | 7,330.00 |